Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Sales | 146.45 | 155.99 | 135.62 | 112.46 | 133.77 |
| Operating profit | 29.66 | 31.15 | 20.72 | 16.60 | 26.75 |
| Interest | 0.15 | 0.39 | 0.41 | 1.15 | 0.33 |
| Gross profit | 40.52 | 39.45 | 27.99 | 19.39 | 32.78 |
| EPS (Rs) | 14.00 | 13.81 | 9.49 | 6.27 | 10.79 |
Quarterly
results in details
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Other income | 11.02 | 8.69 | 7.69 | 3.95 | 6.36 |
| Stock adjustment | -20.30 | 4.20 | 5.71 | 4.49 | -4.42 |
| Raw material | 56.88 | 49.66 | 42.70 | 33.97 | 47.74 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 26.44 | 24.94 | 26.47 | 23.05 | 23.44 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 53.77 | 46.03 | 40.03 | 34.35 | 40.25 |
| Provisions made | - | - | - | - | - |
| Depreciation | 2.81 | 2.58 | 2.55 | 2.41 | 2.26 |
| Taxation | 9.67 | 9.21 | 6.43 | 4.42 | 8.90 |
| Net profit / loss | 28.04 | 27.65 | 19.01 | 12.56 | 21.61 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 20.03 | 20.03 | 20.03 | 20.03 | 20.03 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 20.25 | 19.97 | 15.27 | 14.76 | 20.00 |
| GPM (%) | 25.73 | 23.95 | 19.53 | 16.66 | 23.39 |
| NPM (%) | 17.81 | 16.79 | 13.27 | 10.79 | 15.42 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis